Skip to content

Comparison of the effect of aromatherapy and edible rose essential oil on saliva cortisol level and quality of life of chronic renal failure patients undergoing hemodialysis

Comparison of the effect of aromatherapy and edible rose essential oil on saliva cortisol level and quality of life of chronic renal failure patients undergoing hemodialysis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200610047725N1
Enrollment
72
Registered
2023-04-18
Start date
2020-10-03
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic renal failure under hemodialysis. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group number 1 (aroma therapy): When the patient is connected to the dialysis machine, a piece of cloth soaked in 3 drops of rose essence with a concentration of 2% is att

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ability to communicate and answer questions Consent to participate in the study and sign the informed consent form Healthy sense of smell Not having an anxiety disorders Not having a history of using aromatherapy Not having asthma and allergies Not brushing teeth At least three months have passed since hemodialysis Doing dialysis at least 2 to 3 times a week Not taking corticosteroids and immunosuppressants Not having active infection Not having a history of organ transplant rejection Dialysis in the morning shift No history of cancer

Exclusion criteria

Exclusion criteria: Allergy to Rosa damascene and patient reaction to it Taking anti-anxiety and anti-depressant drugs Performing a kidney transplant during the study Change of dialysis method from hemodialysis to peritoneal dialysis during the intervention Hospitalization in the intensive care unit during the intervention

Design outcomes

Primary

MeasureTime frame
Salivary cortisol levels. Timepoint: Salivary cortisol levels at the beginning of the study (before the intervention) and one month later. Method of measurement: By ELISA kits.;Quality of life. Timepoint: Quality of life at the beginning of the study (before the intervention) and one month later. Method of measurement: Kidney Disease Quality of Life-Short Form (KDQOL-SF) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Taheri

Yasouj University of Medical Sciences

t60.taheri@gmail.com+98 74 3322 1350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026